BWXT reports higher second-quarter revenue and profit
BWXT posted 2Q26 revenue of $901.6 million, up 18% from a year earlier.
GAAP net income rose 14% to $89.1 million; diluted GAAP EPS increased 14% to $0.97.
Adjusted EBITDA climbed 7% to $155.5 million; non-GAAP EPS rose 5% to $1.07.
Commercial Operations revenue more than doubled to $302.5 million, while Government Operations revenue edged up 2% to $601.3 million.
BWXT announced the sale of its medical business and raised its 2026 adjusted EBITDA outlook to $662 million-$672 million and non-GAAP EPS to $4.70-$4.80.
BWXT•
